_logo_256_384.jpg){kind=logo}
Healthcare | August 04, 2021
Illumina donates US $ I million in sequencing capabilities to BMC in Mumbai
It supports sequencing-based COVID 19 surveillance in India
It supports sequencing-based COVID 19 surveillance in India
Robust demand for the product across the Middle East, Africa and Latin America
Nureca Ltd has reported financial results for the period ended June 30, 2021.
It works as an adjunct to standard care based on robust clinical trials
The Phase III clinical trial for NONS is expected to be completed by Q4 2021.
WHO prequalification enables the procurement of ROTAVAC 5D by UN agencies namely UNICEF and PAHO
ADG20, a novel monoclonal antibody targeting the spike protein of SARS-CoV-2 and related coronaviruses
Earlier, the USFDA has granted ‘Orphan Drug Designation’ and ‘Fast Track Designation’ to Saroglitazar Mg for PBC
As of 2025, the new Translational Science Center will offer room for more than 500 scientists, who will conduct research in a wide variety of fields ranging from the identification of disease biomarkers to the development of targeted therapies
The companies anticipate clinical studies to begin in August, subject to regulatory approvals
Subscribe To Our Newsletter & Stay Updated
